BACKGROUND: Medication nonadherence and depressive symptoms predict hospitalization and death in patients with heart failure (HF). Depressed patients have lower medication adherence than nondepressed patients. However, the predictive power of the combination of medication adherence and depressive symptoms for hospitalization and death has not been investigated in patients with HF. OBJECTIVE: The aim of this study was to explore the combined influence of medication adherence and depressive symptoms for prediction of cardiac event-free survival in patients with HF. METHODS AND RESULTS: We monitored medication adherence in 216 HF patients who completed the Patient Health Questionnaire-9 (PHQ-9) at baseline. Medication adherence was measured objectively with the use of the Medication Event Monitoring System (MEMS). Patients were followed for up to 3.5 years to collect data on cardiac events. Survival analyses were used to compare cardiac event-free survival among groups. The risk of experiencing a cardiac event for patients with medication nonadherence and depressive symptoms was 5 times higher than those who were medication adherent without depressive symptoms. The risk of experiencing a cardiac event for patients with only 1 risk factor was 1.2-1.3 times that of those with neither risk factor. CONCLUSIONS: Medication nonadherence and depressive symptoms had a negative synergistic effect on cardiac event-free survival in patients with HF.
BACKGROUND: Medication nonadherence and depressive symptoms predict hospitalization and death in patients with heart failure (HF). Depressedpatients have lower medication adherence than nondepressed patients. However, the predictive power of the combination of medication adherence and depressive symptoms for hospitalization and death has not been investigated in patients with HF. OBJECTIVE: The aim of this study was to explore the combined influence of medication adherence and depressive symptoms for prediction of cardiac event-free survival in patients with HF. METHODS AND RESULTS: We monitored medication adherence in 216 HF patients who completed the Patient Health Questionnaire-9 (PHQ-9) at baseline. Medication adherence was measured objectively with the use of the Medication Event Monitoring System (MEMS). Patients were followed for up to 3.5 years to collect data on cardiac events. Survival analyses were used to compare cardiac event-free survival among groups. The risk of experiencing a cardiac event for patients with medication nonadherence and depressive symptoms was 5 times higher than those who were medication adherent without depressive symptoms. The risk of experiencing a cardiac event for patients with only 1 risk factor was 1.2-1.3 times that of those with neither risk factor. CONCLUSIONS: Medication nonadherence and depressive symptoms had a negative synergistic effect on cardiac event-free survival in patients with HF.
Authors: Jennifer L Francis; Ali A Weinstein; David S Krantz; Mark C Haigney; Phyllis K Stein; Peter H Stone; John S Gottdiener; Willem J Kop Journal: Psychosom Med Date: 2009-08-06 Impact factor: 4.312
Authors: Amrut V Ambardekar; Gregg C Fonarow; Adrian F Hernandez; Wenqin Pan; Clyde W Yancy; Mori J Krantz Journal: Am Heart J Date: 2009-10 Impact factor: 4.749
Authors: Richard A Hansen; Stacie B Dusetzina; Liping Song; Bradley N Gaynes; Wanzhu Tu; Michael D Murray Journal: J Am Pharm Assoc (2003) Date: 2009 Nov-Dec
Authors: Hermann Faller; Stefan Störk; Michael Schuler; Marion Schowalter; Thomas Steinbüchel; Georg Ertl; Christiane E Angermann Journal: J Card Fail Date: 2008-12-25 Impact factor: 5.712
Authors: Romano Endrighi; Andrew J Waters; Stephen S Gottlieb; Kristie M Harris; Andrew J Wawrzyniak; Nadine S Bekkouche; Yisheng Li; Willem J Kop; David S Krantz Journal: Heart Date: 2016-06-29 Impact factor: 5.994
Authors: Nancy S Redeker; Andrea K Knies; Christopher Hollenbeak; H Klar Yaggi; John Cline; Laura Andrews; Daniel Jacoby; Anna Sullivan; Meghan O'Connell; Joanne Iennaco; Lisa Finoia; Sangchoon Jeon Journal: Contemp Clin Trials Date: 2017-01-31 Impact factor: 2.226
Authors: Emily C Gathright; Mary A Dolansky; John Gunstad; Joseph D Redle; Richard A Josephson; Shirley M Moore; Joel W Hughes Journal: Health Psychol Date: 2017-07-20 Impact factor: 4.267
Authors: S Neubauer; T Schilling; J Zeidler; A Lange; S Engel; R Linder; F Verheyen; J-M Graf von der Schulenburg; A Haverich Journal: Herz Date: 2016-02-16 Impact factor: 1.443